Favorable Environments

Recorded in-person in Minneapolis, this conversation reflects the kind of cross-regional connections shaping the Midwest’s medtech and biotech ecosystem. In this episode of Favorable Environments, Tung Nguyen speaks with Ian Weimer, Founder of Weimer Analytics, about bringing real world evidence and advanced health economics analytics to small and medium-sized medtech and biotech companies. Ian brings experience from a boutique healthcare consultancy where he contributed to 16 peer-reviewed pu

In this episode of Favorable Environments, Tung Nguyen speaks with Dr. Patrick Rynn Hogan, DHA, author of the newly published book The Silent Pandemic of Antimicrobial Resistance: Why the Next Global Health Crisis Has Already Begun and CEO of Prescient Healthcare, about one of the most urgent yet under-recognized threats to modern health. Dr. Hogan explains antimicrobial resistance (AMR) as a system-level failure spanning healthcare infrastructure, agricultural practices, supply chains, and inno

In this episode of Favorable Environments, Host Tung Nguyen speaks with fellow members of theUSD Discovery District leadership team—Ryan, President; Marc, Director of Biotech Development; in a reflective discussion—about the organization's first operational year since taking possession of Building 1 in January 2025. The team shares candid insights into the milestones achieved, the challenges navigated, and the strategic pivots that have positioned the District as a purpose-built hub for bioscien

In this episode of Favorable Environments, Tung Nguyen speaks with Dr. Kristina Harris Jackson, Director of Research at OmegaQuant Analytics, about how a science-first company in Sioux Falls became a global leader in fatty acid testing. Kristina shares the story of OmegaQuant’s founding, the research legacy of Dr. Bill Harris, and how the company grew from an academic idea into one of the most trusted diagnostic tools in the world. With more than a million Omega-3 Index tests performed, partners

Today, we sit down with Fabrice Paublant, CEO of Orixha, whose 30-year career in pharmaceuticals and consulting drives his passion for transformative medical innovation. In this episode, Mr. Paublant dives into Orixha’s pioneering liquid ventilator for post-cardiac arrest care, sharing insights on leadership, mentorship, and strategic cash management. The content in this episode is not financial or legal advice. Please consult a qualified professional for investment guidance. This podcast is s

Join the USD Discovery District for an insightful conversation with Wassim Laroussi, founder of The Biotech Investor YouTube channel. From his early days as a pharmacy technician to a career in software development, Larussi’s passion for finance led him to launch his channel in 2020. He now delivers in-depth analyses of public biotech companies, their groundbreaking innovations, and stock performance in the public markets. Discover his unique journey and expert insights into biotech investing.